Company Discovery Laboratories, Inc. Nasdaq
Equities
US2546684034
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 31/01/16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 08/03/20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 19/05/14 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 31/10/13 |
Diane Carman
LAW | General Counsel | 55 | 30/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 02/02/21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 21/06/23 |
Leslie Williams
BRD | Director/Board Member | 64 | 02/02/21 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 31/01/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 510,178 | 486,423 ( 95.34 %) | 0 ( 0.000011 %) | 95.34 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- WINT Stock
- Stock
- Company Discovery Laboratories, Inc.